Lysosomal alterations in peripheral blood mononuclear cells of Parkinson's disease patients

Movement Disorders : Official Journal of the Movement Disorder Society
Nikolaos PapagiannakisLeonidas Stefanis

Abstract

Reduced expression of lysosomal-associated membrane protein 2a and heatshock-cognate 70 proteins, involved in chaperone-mediated autophagy and of glucocerebrosidase, is reported in PD brains. The aim of this study was to identify systemic alterations in lysosomal-associated membrane protein 2a, heatshock cognate-70, and glucocerebrosidase levels/activity in peripheral blood mononuclear cells from PD patients. Protein/mRNA levels were assessed in PD patients from genetically undetermined background, alpha-synuclein (G209A/A53T), or glucocerebrosidase mutation carriers and age-/sex-matched controls. Heatshock cognate 70 protein levels were reduced in all PD groups, whereas its mRNA levels were decreased only in the genetically undetermined group. Glucocerebrosidase protein levels were decreased only in the genetic PD groups, whereas increased mRNA levels and decreased activity were detected only in the glucocerebrosidase mutation group. Reduced heatshock cognate-70 levels are suggestive of an apparent systemic chaperone-mediated autophagy dysfunction irrespective of genetic background. Glucocerebrosidase activity may serve as a screening tool to identify glucocerebrosidase mutation carriers with PD.

References

Aug 1, 1990·Trends in Biochemical Sciences·J F Dice
Aug 28, 1997·Nature·M G SpillantiniM Goedert
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniM Goedert
Apr 6, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ashish C MasseyAna Maria Cuervo
Jun 21, 2008·The Journal of Biological Chemistry·Tereza VogiatziLeonidas Stefanis
Dec 17, 2008·Combinatorial Chemistry & High Throughput Screening·Daniel J UrbanChristopher P Austin
Aug 11, 2010·Archives of Neurology·Lydia Alvarez-ErvitiAnthony H V Schapira
Sep 15, 2010·Acta Neuropathologica·Ozlem Goker-AlpanEllen Sidransky
Jul 13, 2011·Molecular Genetics and Metabolism·Marina MoraitouHelen Michelakakis
Jul 19, 2012·Acta Neuropathologica·Henry Houlden, Andrew B Singleton
Oct 5, 2012·Annals of Neurology·Matthew E GeggAnthony H V Schapira
Apr 13, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Benjamin DehayErwan Bezard
Aug 8, 2013·Nature Medicine·Ralph A Nixon
Dec 10, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M BoziL Stefanis
Jan 31, 2014·Brain : a Journal of Neurology·Karen E MurphyGlenda M Halliday
Oct 30, 2014·Brain : a Journal of Neurology·Ianai FishbeinRobert L Nussbaum
Jan 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Karen E MurphyGlenda M Halliday

❮ Previous
Next ❯

Citations

Aug 4, 2016·Ageing Research Reviews·Maria Xilouri, Leonidas Stefanis
Nov 9, 2016·Translational Neurodegeneration·Bao WangQian Yang
Sep 16, 2017·Parkinson's Disease·Erik L FriesenSuneil K Kalia
Sep 7, 2018·Expert Opinion on Therapeutic Targets·Philip CampbellAnthony Schapira
Jun 22, 2019·Journal of Neurology, Neurosurgery, and Psychiatry·Micol AvenaliAnthony H V Schapira
Apr 3, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jing ZouAnding Xu
Jan 10, 2017·Frontiers in Molecular Neuroscience·Gessica SalaCarlo Ferrarese
Feb 16, 2019·Frontiers in Endocrinology·Iván E AlfaroMauricio Budini
Aug 13, 2020·International Journal of Molecular Sciences·Clara RuzSara Bandres-Ciga
Mar 25, 2019·Pharmacology Research & Perspectives·Fernando L PaganCharbel Moussa
Mar 7, 2020·Frontiers in Molecular Neuroscience·Fernando OrmeñoMauricio Budini
Oct 20, 2018·Scientific Reports·Farzaneh AtashrazmNicolas Dzamko
Oct 19, 2020·Molecular Neurodegeneration·Karim BelarbiMarie-Christine Chartier-Harlin
Nov 26, 2019·Molecular Genetics and Metabolism·Parker H JohnsonReena V Kartha
Feb 23, 2021·Movement Disorders : Official Journal of the Movement Disorder Society·Micol AvenaliFabio Blandini
Feb 13, 2021·British Journal of Clinical Pharmacology·Jonas M den HeijerGeert Jan Groeneveld
Feb 18, 2020·Journal of Molecular Biology·Xu HouWolfdieter Springer
Apr 10, 2021·Biophysical Chemistry·Sonia Sanz MuñozCéline Galvagnion
Apr 11, 2021·Biogerontology·I AlmeidaA Nunes
Jun 22, 2021·Frontiers in Neurology·Sophia R L Vieira, Huw R Morris
Sep 4, 2020·Journal of Neurochemistry·Marah C RuntschStefano Angiari
Jul 9, 2021·Annual Review of Neuroscience·Gabriel E Vázquez-Vélez, Huda Y Zoghbi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Karen E MurphyGlenda M Halliday
Archives of Neurology
Lydia Alvarez-ErvitiAnthony H V Schapira
Movement Disorders : Official Journal of the Movement Disorder Society
Evgenii NuzhnyiSofya Pchelina
Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Zhong-lin LiuEn-xiang Tao
© 2022 Meta ULC. All rights reserved